CLINICAL_TRIALS
trial_result
· 2016-07-12
Clinical Trial Update: Extension Study to Evaluate the Long Term Safety and Efficacy of Denosumab in the Treatment of Osteoporosis [Phase 3]
Summary
Extension study evaluating long-term safety and efficacy of denosumab for osteoporosis, completed Phase 3.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Amgen | Conditions: Osteopenia, Osteoporosis | Phase 3 | Status: COMPLETED | Results posted: 2016-07-12